| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |